LeBlanc, Christopher Thomas Francis

Insider profile

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 85% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
LeBlanc, Christopher Thomas Francis's trades of Nova Leap Health Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-06-13 2025-06-13 B Purchase
7,494 +18.5%
180.72
CA$2,241,401
7,494 +18.5% 180.72 CA$2,241,401
2023-12-13 2023-12-13 B Purchase
13,354 +41.1%
311.73
CA$467,517
13,354 +41.1% 311.73 CA$467,517
2023-12-13 2023-12-12 B Purchase
83,746 -46.7%
442.47
CA$4,598,521
83,746 -46.7% 442.47 CA$4,598,521
2023-08-30 2023-08-30 B Purchase
20,000 +17.9%
0.18
CA$3,500
20,000 +17.9% 0.18 CA$3,500
2023-08-29 2023-08-28 B Purchase
20,000 +21.9%
0.18
CA$3,586
20,000 +21.9% 0.18 CA$3,586
2023-08-29 2023-08-28 B Purchase
20,000 +28.0%
0.17
CA$3,466
20,000 +28.0% 0.17 CA$3,466